Abstract
Overactive pelvic floor (OPF) is understood to be a multifactorial condition requiring a multidisciplinary medical, psychological, and physical therapy team. Pelvic floor overactivity rarely exists as an isolated condition, but is related to several neurological, musculoskeletal, urological, oncological, gynecological, and gastroenterological presentations. The following chapter examines the evidence-based literature regarding medical interventions for the treatment of OPF muscle dysfunction. Medications that can be used to decrease muscular hypertonus and reduce neuronal activity will be examined.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Goldstein A. Medical history, physical examination, and laboratory tests for the evaluation of dyspareunia. In: Goldstein A, Pukall C, Goldstein I, editors. Female sexual pain disorders: evaluation and management. Chichester: Blackwell-Wiley; 2009.
King M, Rubin R, Goldstein A. Current uses of surgery for the treatment of genital pain. Curr Sex Health Rep. 2014;6(4):252–8. doi:10.1007/s11930-014-0032-8.
Abbott J. Gynecological indications for the use of botulinum toxin in women with chronic pelvic pain. Toxicon. 2009;54(5):647–53.
Adelowo A, Hacker M, Shapiro A, Merport Modest A, Elkadry E. Botulinum toxin type A (BOTOX) for refractory myofascial pelvic pain. Female Pelvic Med Reconstr Surg. 2013;19(5):288–92.
Moldwin R, Fariello JY. Myofascial trigger points of the pelvic floor: associations with urologic pain syndromes and treatment strategies including injection therapy. Curr Urol Rep. 2013;14(5):409–17.
Nesbitt-Hawes EM, Won H, Jarvis SK, Lyons SD, Vancaillie TG, Abbott JA. Improvement in pelvic pain with botulinum toxin type A—single vs. repeat injections. Toxicon. 2013;63(1):83–7.
Rogalski MJ, Kellogg-Spadt S, Hoffmann AR, Fariello JY, Whitmore KE. Retrospective chart review of vaginal diazepam suppository use in high-tone pelvic floor dysfunction. Int Urogynecol J. 2010;21(7):895–9.
Crisp CC, Vaccaro CM, Estanol MV, Oakley SH, Kleeman SD, Fellner AN, Pauls RN. Intra-vaginal diazepam for high-tone pelvic floor dysfunction: a randomized placebo-controlled trial. Int Urogynecol J. 2013;24(11):1915–23.
Sheikh M, Kunka C, Ota K. Treatment of levator ani syndrome with cyclobenzaprine. Pharmacology and pharmacy. Ann Pharmacother. 2012;46(10):e29.
Garrick JG. Topical nitroglycerin decreases pain intensity in daily activities: a review. Clin J Sport Med. 2011;21(6):539–40.
Hashmi F, Memon MM, Khan AM. Efficacy and side effects of glyceryl trinitrate in management of chronic anal fissure. J Ayub Med Coll Abbottabad. 2012;24(1):21–2.
Mari FS, Nigri G, Dall’oglio A, Cosenza UM, Milillo A, Terrenato I, Pancaldi A, Brescia A. Topical glyceryl trinitrate ointment for pain related to anal hypertonia after stapled hemorrhoidopexy: a randomized controlled trial. Dis Colon Rectum. 2013;56(6):768–73.
Sajid MS, Whitehouse PA, Sains P, Baig MK. Systematic review of the use of topical diltiazem compared with glyceryl trinitrate for the nonoperative management of chronic anal fissure. Colorectal Dis. 2013;15(1):19–26.
Tsunoda A, Kashiwagura Y, Hirose K, Sasaki T, Kano N. Quality of life in patients with chronic anal fissure after topical treatment with diltiazem. World J Gastrointest Surg. 2012;4(11):251–5.
Boardman LA, Cooper AS, Blais LR, Raker CA. Topical gabapentin in the treatment of localized and generalized vulvodynia. Obstet Gynecol. 2008;112(3):579–85.
Bharti N, Bala I, Narayan V, Singh G. Effect of gabapentin pretreatment on propofol consumption, hemodynamic variables, and postoperative pain relief in breast cancer surgery. Acta Anaesthesiol Taiwan. 2013;51(1):10–3.
Deniz MN, Sertoz N, Erhan E, Ugur G. Effects of preoperative gabapentin on postoperative pain after radical retropubic prostatectomy. J Int Med Res. 2012;40(6):2362–9.
Poterucha TJ, Murphy SL, Rho RH, Sandroni P, Warndahl RA, Weiss WT, Davis MD. Topical amitriptyline-ketamine for treatment of rectal, genital, and perineal pain and discomfort. Pain Physician. 2012;15(6):485–8.
Pagano R, Wong S. Use of amitriptyline cream in the management of entry dyspareunia due to provoked vestibulodynia. J Low Genit Tract Dis. 2012;16(4):394–7.
Leo RJ, Dewani S. A systematic review of the utility of antidepressant pharmacotherapy in the treatment of vulvodynia pain. J Sex Med. 2013;10:2497–505.
Foster DC, Kotok MB, Huang LS, Watts A, Oakes D, Howard FM, Poleshuck EL, Stodgell CJ, Dworkin RH. Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial. Am J Obstet Gynecol. 2010;116(3):583–93.
Ohnami S, Kato A, Ogawa K, Shinohara S, Ono H, Tanabe M. Effects of milnacipran, a 5-HT and noradrenaline reuptake inhibitor, on C-fibre-evoked field potentials in spinal long-term potentiation and neuropathic pain. Br J Pharmacol. 2012;167(3):537–47.
Giannantoni A, Porena M, Gubbiotti M, Maddonni S, Di Stasi SM. The efficacy and safety of duloxetine in a multidrug regimen for chronic prostatitis/chronic pelvic pain syndrome. Urology. 2014;83(2):400–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Preil, R.N., Belkin, Z.R., Goldstein, A.T. (2016). Medical Therapies for the Treatment of Overactive Pelvic Floor. In: Padoa, A., Rosenbaum, T. (eds) The Overactive Pelvic Floor. Springer, Cham. https://doi.org/10.1007/978-3-319-22150-2_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-22150-2_15
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-22149-6
Online ISBN: 978-3-319-22150-2
eBook Packages: MedicineMedicine (R0)